We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$236M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$31.2M
3
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
+$25M
4
AMAT icon
Applied Materials
AMAT
+$22.1M
5
BAX icon
Baxter International
BAX
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
151
Emerson Electric
EMR
$83.6B
$22.2M 0.1%
236,038
+20,827
+10% +$2.08M
BAX icon
152
Baxter International
BAX
$12.1B
$21.9M 0.1%
272,631
-257,571
-49% -$20.4M
HUM icon
153
Humana
HUM
$45.8B
$21.3M 0.09%
54,726
-21,572
-28% -$9.16M
LH icon
154
Labcorp
LH
$24.7B
$21.1M 0.09%
87,095
+7,683
+10% +$1.94M
NVO
155
Novo Nordisk
NVO
$220B
$20.9M 0.09%
435,428
+5,094
+1% +$246K
MMM icon
156
3M
MMM
$91.9B
$20.5M 0.09%
139,645
+12,322
+10% +$2M
DUK icon
157
Duke Energy
DUK
$100B
$20.4M 0.09%
209,142
+18,453
+10% +$1.91M
SOLN
158
DELISTED
The Southern Company
SOLN
$20.4M 0.09%
400,000
– –
DE icon
159
Deere & Co
DE
$169B
$20.3M 0.09%
60,598
+5,337
+10% +$1.92M
VRTX icon
160
Vertex Pharmaceuticals
VRTX
$122B
$20.1M 0.09%
110,957
-17,046
-13% -$3.33M
AEPPZ
161
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
$19.9M 0.09%
400,000
-20,000
-5% -$1.05M
ROKU icon
162
Roku
ROKU
$21.2B
$19.7M 0.09%
63,018
+56,318
+841% +$21.2M
COP icon
163
ConocoPhillips
COP
$141B
$19.6M 0.09%
288,958
+25,498
+10% +$1.47M
USB icon
164
US Bancorp
USB
$98.9B
$19.6M 0.09%
328,916
+15,606
+5% +$889K
IBM icon
165
IBM
IBM
$204B
$19.5M 0.09%
146,768
+12,950
+10% +$1.73M
MGM icon
166
MGM Resorts International
MGM
$11.8B
$19.4M 0.08%
449,888
+18,072
+4% +$736K
BKNG icon
167
Booking.com
BKNG
$145B
$19.2M 0.08%
202,300
+17,850
+10% +$1.6M
ULTA icon
168
Ulta Beauty
ULTA
$20.7B
$19.1M 0.08%
52,895
+1,475
+3% +$533K
SYK icon
169
Stryker
SYK
$129B
$18.9M 0.08%
71,528
+4,521
+7% +$1.21M
UBS icon
170
UBS Group
UBS
$172B
$18.7M 0.08%
1,174,727
+14,969
+1% +$242K
AIZ icon
171
Assurant
AIZ
$13.7B
$18.6M 0.08%
117,903
+7,698
+7% +$1.24M
JETS icon
172
CALL
US Global Jets ETF
JETS
$768M
$18.6M 0.08%
+785,000
New +$18.1M
LYFT icon
173
Lyft
LYFT
$5.73B
$18.5M 0.08%
345,991
+31,088
+10% +$1.65M
CBOE icon
174
Cboe Global Markets
CBOE
$30.2B
$18.5M 0.08%
149,297
+13,172
+10% +$1.61M
FRC
175
DELISTED
First Republic Bank
FRC
$18.2M 0.08%
94,528
+8,341
+10% +$1.64M
5 6
7
8 9

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.